Literature DB >> 26187454

Impaired adrenal medullary function in a mouse model of depression induced by unpredictable chronic stress.

Magda M Santana1, Joana Rosmaninho-Salgado2, Vera Cortez2, Frederico C Pereira3, Manuella P Kaster4, Célia A Aveleira2, Marisa Ferreira2, Ana Rita Álvaro2, Cláudia Cavadas5.   

Abstract

Stress has been considered determinant in the etiology of depression. The adrenal medulla plays a key role in response to stress by releasing catecholamines, which are important to maintain homeostasis. We aimed to study the adrenal medulla in a mouse model of depression induced by 21 days of unpredictable chronic stress (UCS). We observed that UCS induced a differential and time-dependent change in adrenal medulla. After 7 days of UCS, mice did not show depressive-like behavior, but the adrenal medullae show increased protein and/or mRNA levels of catecholamine biosynthetic enzymes (TH, DβH and PNMT), Neuropeptide Y, the SNARE protein SNAP-25, the catecholamine transporter VMAT2 and the chromaffin progenitor cell markers, Mash1 and Phox2b. Moreover, 7 days of UCS induced a decrease in the chromaffin progenitor cell markers, Sox9 and Notch1. This suggests an increased capacity of chromaffin cells to synthesize, store and release catecholamines. In agreement, after 7 days, UCS mice had higher NE and EP levels in adrenal medulla. Opposite, when mice were submitted to 21 days of UCS, and showed a depressive like behavior, adrenal medullae had lower protein and/or mRNA levels of catecholamine biosynthetic enzymes (TH, DβH, PNMT), catecholamine transporters (NET, VMAT1), SNARE proteins (synthaxin1A, SNAP25, VAMP2), catecholamine content (EP, NE), and lower EP serum levels, indicating a reduction in catecholamine synthesis, re-uptake, storage and release. In conclusion, this study suggests that mice exposed to UCS for a period of 21 days develop a depressive-like behavior accompanied by an impairment of adrenal medullary function.
Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26187454     DOI: 10.1016/j.euroneuro.2015.06.013

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  5 in total

1.  Altered Expression of Phox2 Transcription Factors in the Locus Coeruleus in Major Depressive Disorder Mimicked by Chronic Stress and Corticosterone Treatment In Vivo and In Vitro.

Authors:  Yan Fan; Ping Chen; Muhammad U Raza; Attila Szebeni; Katalin Szebeni; Gregory A Ordway; Craig A Stockmeier; Meng-Yang Zhu
Journal:  Neuroscience       Date:  2018-10-11       Impact factor: 3.590

Review 2.  SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond.

Authors:  Renata Basso Cupertino; Djenifer B Kappel; Cibele Edom Bandeira; Jaqueline Bohrer Schuch; Bruna Santos da Silva; Diana Müller; Claiton Henrique Dotto Bau; Nina Roth Mota
Journal:  J Neural Transm (Vienna)       Date:  2016-02-08       Impact factor: 3.575

3.  Protective Effects of Agmatine Against Corticosterone-Induced Impairment on Hippocampal mTOR Signaling and Cell Death.

Authors:  Gislaine Olescowicz; Tuane B Sampaio; Cristine de Paula Nascimento-Castro; Patricia S Brocardo; Joana Gil-Mohapel; Ana Lúcia S Rodrigues
Journal:  Neurotox Res       Date:  2020-05-12       Impact factor: 3.911

Review 4.  Neuronal correlates of depression.

Authors:  Dipesh Chaudhury; He Liu; Ming-Hu Han
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

5.  Midlife stress alters memory and mood-related behaviors in old age: Role of locally activated glucocorticoids.

Authors:  Nicola Wheelan; Christopher J Kenyon; Anjanette P Harris; Carolynn Cairns; Emad Al Dujaili; Jonathan R Seckl; Joyce L W Yau
Journal:  Psychoneuroendocrinology       Date:  2017-12-23       Impact factor: 4.905

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.